Literature DB >> 23409988

Characterization of AQP-2 gene mutation (R254Q) in a family with dominant nephrogenic DI.

Yoko Shida1, Hisafumi Matsuoka, Motoko Chiga, Shinichi Uchida, Sei Sasaki, Shigetaka Sugihara.   

Abstract

We identified the AQP-2 gene mutation (R254Q) in a family with dominant NDI. The patient studied here has NDI with partial response to the anti-diuretic effect of AVP and dDAVP. Hereditary NDI seems to have the uniform clinical manifestations, but this might only reflect the information on screened patients with clear clinical presentations. It may be that a milder form of NDI has been overlooked due to a lack of genetic identification. Gene mutation analysis should be considered even in patients with mild NDI symptoms. Fortunately, both V2R and AQP2 genes are small and can be easily analyzed.
© 2013 The Authors. Pediatrics International © 2013 Japan Pediatric Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23409988     DOI: 10.1111/j.1442-200X.2012.03614.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  4 in total

1.  Novel autosomal recessive gene mutations in aquaporin-2 in two Chinese congenital nephrogenic diabetes insipidus pedigrees.

Authors:  Jing Cen; Min Nie; Lian Duan; Feng Gu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan.

Authors:  Masanobu Fujimoto; Shin-Ichi Okada; Yuki Kawashima; Rei Nishimura; Naoki Miyahara; Yasuo Kawaba; Keiichi Hanaki; Eiji Nanba; Yoshiaki Kondo; Takashi Igarashi; Susumu Kanzaki
Journal:  Yonago Acta Med       Date:  2014-07-30       Impact factor: 1.641

3.  A Rare Case of Congenital Diabetes Insipidus.

Authors:  Tanvi Rege; Srujana Polsani; Belinda Jim
Journal:  Front Med (Lausanne)       Date:  2015-07-07

4.  A Case of Congenital Nephrogenic Diabetes Insipidus Caused by Thr108Met Variant of Aquaporin 2.

Authors:  Lina Ma; Dengyan Wu; Xingmin Wang; Yonghong Yang
Journal:  Front Pediatr       Date:  2020-01-30       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.